[go: up one dir, main page]

JPS607961B2 - fair skin cosmetics - Google Patents

fair skin cosmetics

Info

Publication number
JPS607961B2
JPS607961B2 JP52160732A JP16073277A JPS607961B2 JP S607961 B2 JPS607961 B2 JP S607961B2 JP 52160732 A JP52160732 A JP 52160732A JP 16073277 A JP16073277 A JP 16073277A JP S607961 B2 JPS607961 B2 JP S607961B2
Authority
JP
Japan
Prior art keywords
acid
kojic acid
asbergillus
examples
esterified product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52160732A
Other languages
Japanese (ja)
Other versions
JPS5492632A (en
Inventor
純義 長井
外喜雄 泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Priority to JP52160732A priority Critical patent/JPS607961B2/en
Publication of JPS5492632A publication Critical patent/JPS5492632A/en
Publication of JPS607961B2 publication Critical patent/JPS607961B2/en
Expired legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)

Description

【発明の詳細な説明】 本発明は新規な色白化粧料に関する。[Detailed description of the invention] The present invention relates to a novel whitening cosmetic.

さらに詳しくは、一般式(1);(式中、Rは飽和また
は不飽和脂肪族炭化水素基である)で示されるコウジ酸
のェステル化物を有効成分として含有せしめた美白効果
および日暁防止効果の大なる色白化粧料に関する。
More specifically, the skin whitening effect and sun protection effect of containing an esterified product of kojic acid represented by the general formula (1); (wherein R is a saturated or unsaturated aliphatic hydrocarbon group) as an active ingredient. Regarding the great whitening cosmetics.

色白の美しい肌にしたいと願うのは女性の常であり、従
来より過酸化水素、過酸化亜鉛、過酸化マグネシウム、
過酸化ナトリウム、過ホウ酸亜鉛、過ホゥ酸マグネシウ
ムまたは過ホゥ酸ナトリウムなどの過酸化物を配合した
化粧料が広く使用されていた。
It is common for women to want to have fair and beautiful skin, and traditionally, hydrogen peroxide, zinc peroxide, magnesium peroxide,
Cosmetics containing peroxides such as sodium peroxide, zinc perborate, magnesium perborate, or sodium perborate have been widely used.

しかしながら前記のごとき過酸化物は保存性、物理的ま
たは化学的安定性あるいは化粧料への配合性の面で問題
があり、かつその美白効果も充分ではなかった。近年に
なって、ビタミンC、システィソ、コロイド硫黄などを
配合した化粧料が開発され賞用されているが、これらと
てもなお充分に満足しうる保存性、安定性および美白効
果を有するものとはいいがたい。しかるに、本発明者ら
は人体に好ましくない副作用を有せず、かつすぐれた美
白効果および日焼防止効果を奏しうる美白剤を見出すべ
く種々研究を重ねた結果、前記一般式(1)で示される
コウジ酸のェステル化物が人体皮膚内に存在するチロジ
ナーゼの活性を阻害して顕著なメラニン生成抑制作用を
示し、すぐれた美白効果および日焼防止効果を奏しうる
とともに、pH、光、熱などに対す・る安定性が大きく
保存性がすこぶる良好であり、さらに該ェステル化物は
油溶性にすべれており、クリームなどに配合されたぱあ
し、、容易に油層に溶解するためにその皮膚吸収性がき
わめて良好であるという新たな事実を見出し、本発明を
完成するにいたつた。
However, the above-mentioned peroxides have problems in terms of storage stability, physical or chemical stability, or incorporation into cosmetics, and their whitening effect is also insufficient. In recent years, cosmetics containing vitamin C, cystisoline, colloidal sulfur, etc. have been developed and used, but it is said that these products still have satisfactory shelf life, stability, and whitening effects. It's tough. However, the present inventors have conducted various studies to find a skin whitening agent that does not have any unfavorable side effects on the human body and has excellent skin whitening and sun protection effects. The esterified product of kojic acid inhibits the activity of tyrosinase present in the human skin, exhibiting a remarkable melanin production inhibiting effect, and exhibiting excellent whitening and sun protection effects, as well as being effective against pH, light, heat, etc. In addition, the esterified product is highly oil-soluble and easily dissolves in the oil layer of creams, etc., making it difficult to absorb into the skin. The present invention was completed based on the new discovery that the properties of the present invention are extremely good.

本発明の色白化粧料に有効成分として配合される前記一
般式(1)で示されるコウジ酸のェステル化物はコウジ
酸と脂肪族カルボン酸との塩化亜鉛などの触媒の存在下
でェステル化反応せしめることにより容易にえられる。
The esterified product of kojic acid represented by the general formula (1), which is incorporated as an active ingredient in the fairing cosmetic composition of the present invention, is subjected to an esterification reaction between kojic acid and an aliphatic carboxylic acid in the presence of a catalyst such as zinc chloride. It can be easily obtained by

本発明において用いられるコウジ酸としては、純品のコ
ウジ酸またはァスベルギルス属、ベニシリウム属、ェス
カリキア属、アセトバクター属およびグルコノバクタ−
属よりなる群から選ばれた属の菌株であってコウジ酸生
産館を有するものを培養してえられるところのコウジ酸
を主成分とする発酵液からコウジ酸を抽出し結晶化した
ものがあげられる。
The kojic acid used in the present invention includes pure kojic acid or those of the genus Asbergillus, Benicillium, Escalychia, Acetobacter, and Gluconobacter.
It is a product obtained by extracting and crystallizing kojic acid from a fermentation liquid containing kojic acid as its main component, which is obtained by culturing a strain of a genus selected from a group consisting of genus that has a kojic acid production facility. It will be done.

ここにコウジ酸生産能を有するアスベルギルス属の菌株
としてはたとえばアスベルギルス・アル/ゞス、アスベ
ルギルス・力ンジダス、アスベルギルス・オリゼー、ア
スベルギルス・ニデユランス、アスベルギルス・/fラ
シテイカス、アスベルギルス・アワモリ、アスベルギル
ス・タマリ、アスベルギルス・ニービユース、アスベル
ギルス・フラ/ゞス、アスベルギルス・ウエンチ、アス
ベルギルス・グラウカス、アスベルギルス・クラベイタ
ス、アスベルギルス・フミガタス、アスベルギルス・ジ
ガンタスなどの菌株が、またべニシリウム属の菌株とし
てはたとえばべニシリウム・ダレ−などの菌株が、また
ェスカリキァ属の菌株としてはたとえばェスカリキア・
コリなどの菌株が、またアセトバクタ−属の菌株として
はたとえばアセトバクター・アセチ、アセトバクター・
グルコニカス、アセトバクター・キシリナムなどの菌株
が、またグルコノバクター属の菌株としてはたとえばグ
ルコノバクター・ロシウス、グルコノバクター・グルコ
ニカスなどの菌株が好適に採用されうる。これらの菌株
の培地組成としては、通常ショ糖、果糖、ブドウ糖、デ
ンプン、麦芽糖、グリセリン、マンニツト、ラムノース
、キシロース、グルコン酸、アラビノース、ジヒドロキ
シアセトン、イノシツト、ラクトース、エタノールなど
の炭素源が約2〜15%(重量%、以下同様)、硫酸ア
ンモニア、ポリベプトン、硝酸ソーダ、パン酵母抽出物
、ビール酵母抽出物などのチッ素源が約0.1〜1%、
硫酸マグネシウムなどのマグネシウム源が約0.01〜
0.05%「リン酸1水素カリ、リン酸2水素カーjな
どのリンおよびカリウム源が0.01〜0.1%、その
他硫酸第二鉄、塩化第二鉄、塩化ナトリウム、塩化カル
シウムなどの無機塩が約0.001〜0.005%のも
のが採用されうる。
Here, examples of strains of the genus Asbergillus having the ability to produce kojic acid include Asbergillus al/us, Asbergillus straindus, Asbergillus oryzae, Asbergillus nidulans, Asbergillus rashiticus, and Asbergillus. Strains such as Awamori, Asbergillus tamari, Asbergillus niebieus, Asbergillus fura/su, Asbergillus wench, Asbergillus glaucus, Asbergillus clavaitus, Asbergillus fumigatus, Asbergillus digitus, etc. Examples of strains of the genus Benicillium include strains such as Benicillium dale; examples of strains of the genus Escalychia include, for example, Escalychia.
strains such as Acetobacter coli, and Acetobacter strains such as Acetobacter aceti and Acetobacter aceti.
Bacterial strains such as Gluconicus and Acetobacter xylinum can be suitably employed, and strains of the genus Gluconobacter such as Gluconobacter rosius and Gluconobacter gluconicus can be suitably employed. The culture medium composition of these strains usually contains about 2 to 3 carbon sources such as sucrose, fructose, glucose, starch, maltose, glycerin, mannite, rhamnose, xylose, gluconic acid, arabinose, dihydroxyacetone, inosyte, lactose, and ethanol. 15% (wt%, the same applies hereinafter), about 0.1 to 1% nitrogen sources such as ammonia sulfate, polybeptone, sodium nitrate, baker's yeast extract, brewer's yeast extract, etc.
Magnesium sources such as magnesium sulfate are about 0.01~
0.05% phosphorus and potassium sources such as monohydrogen phosphate and dihydrogen phosphate, 0.01 to 0.1%, and other sources such as ferric sulfate, ferric chloride, sodium chloride, calcium chloride, etc. About 0.001 to 0.005% of inorganic salts may be used.

しかして用いる菌株の種類およびその培地組成などによ
って含有成分組成の異なる発酵液がえられるが「いずれ
の発酵液も主成分として通常0.01〜10%度のコウ
ジ酸が含有されている。かかるコウジ酸含有発酵液より
コウジ酸を抽出し結晶化せしめることによりコウジ酸が
えられる。これらコウジ酸はそれ自体強力なチロジナー
ゼ活性阻害力を有するものであるが、該コウジ酸を脂肪
族カルボン酸と反応させてェステル化物とすることによ
り、そのチロジナーゼ活性阻害力がより増加すると共に
、光、pHに対する安定性が増加して保存安定性がきわ
めて良好となり、さらに油溶性が増加し、クリームなど
に配合するぱあし、、容易に油層に溶解して皮膚吸収性
が増加するなどのすぐれた美白効果および日焼防止効果
を奏しうる。
Therefore, fermented liquids with different compositions of ingredients can be obtained depending on the type of bacterial strain used and the composition of its medium. Kojic acid is obtained by extracting and crystallizing kojic acid from a kojic acid-containing fermentation liquor.These kojic acids themselves have strong tyrosinase activity inhibiting power, but when the kojic acid is converted into an aliphatic carboxylic acid, By reacting to form an ester, its ability to inhibit tyrosinase activity is further increased, and its stability against light and pH is increased, resulting in extremely good storage stability. Furthermore, its oil solubility is increased, and it is incorporated into creams, etc. It has excellent skin whitening and sun protection effects by easily dissolving into the oil layer and increasing skin absorption.

本発明において用いられる前記脂肪族カルボン酸として
は、飽和脂肪族カルボン酸、不飽和脂肪族カルボン酸、
などがあげられる。
The aliphatic carboxylic acids used in the present invention include saturated aliphatic carboxylic acids, unsaturated aliphatic carboxylic acids,
etc.

飽和脂肪族カルボン酸としては、たとえば酢酸、プロピ
オン酸、n−青草酸、iso−吉草酸、メチルエチル酢
酸、トリメチル酢酸、カプロン酸「ェナント酸、カプリ
ル酸、ベラルゴン酸、カプリン酸、ウンデシル酸、ラウ
リン酸、トリデシル酸、ミリスチン酸、ベンタデシル酸
、パルミチン酸、マルガリン酸、ステアリン酸、ノンデ
レル酸、アラキン酸またはリグノセリン酸などが用いら
れるが「酸の皮膚刺激性を低減化せしめるうえで、C8
以上の飽和脂肪族カルボン酸、とりわけC,4〜2oの
飽和脂肪族カルボン酸を用いるのが好ましい。
Saturated aliphatic carboxylic acids include, for example, acetic acid, propionic acid, n-green acid, iso-valeric acid, methylethyl acetic acid, trimethylacetic acid, caproic acid, enanthic acid, caprylic acid, belargonic acid, capric acid, undecylic acid, lauric acid. Acids such as tridecylic acid, myristic acid, bentadecylic acid, palmitic acid, margaric acid, stearic acid, nonderelic acid, arachidic acid or lignoceric acid are used.
It is preferable to use the above saturated aliphatic carboxylic acids, especially C,4-2o saturated aliphatic carboxylic acids.

なおC2。より大きい前記脂肪族カルボン酸はとくにそ
の使用が制限されるものではないが、その入手がきわめ
て困難であるために、製造コストのうえから好ましくな
い。またこれら飽和脂肪族カルボン酸のほかに、たとえ
ばリノール酸、リノレン酸、マレイン酸、フマル酸、オ
レフィン酸またアラキドン酸などの不飽和脂肪族カルボ
ン酸がいずれも特別な制限なしに用いられる。
Furthermore, C2. Although the use of the larger aliphatic carboxylic acids is not particularly limited, they are extremely difficult to obtain and therefore are not preferred in terms of production costs. In addition to these saturated aliphatic carboxylic acids, unsaturated aliphatic carboxylic acids such as linoleic acid, linolenic acid, maleic acid, fumaric acid, olefinic acid and arachidonic acid can be used without any particular limitation.

本発明の色白化粧料は適宜の化粧料基村に前述のごとき
ェステル化物を含有せしめたものであるが、該ヱステル
化物の含有量としては通常0.01〜10%程度、なか
んづく1〜5%程度の範囲が採用される。
The fair skin cosmetic of the present invention contains an esterified product as described above in an appropriate cosmetic base, and the content of the esterified product is usually about 0.01 to 10%, particularly 1 to 5%. A range of degrees will be adopted.

ただし、かかる範囲内で充分に満足しうる美白効果、日
焼防止効果が奏されうるのであって、10%より多量に
含有せしめるときはそれに見合う実益がともなわず、一
方0.1%より少なく含有せしめるときは美白効果、日
焼防止効果の面で若干の不安が残るからである。以上述
べてごとく本発明の色白化粧料は、美白剤としてコウジ
酸のェステル化物を含有せしめることにより、従来品の
欠点を克服しえたものであって、用いる化粧料基材など
によって何ら制限されるものではない。
However, within this range, satisfactorily whitening and sun protection effects can be achieved; however, when the content is greater than 10%, there is no commensurate benefit; on the other hand, the content is less than 0.1%. This is because there are some concerns about the whitening effect and sun protection effect when using it. As described above, the skin-lightening cosmetic of the present invention can overcome the drawbacks of conventional products by containing an esterified product of kojic acid as a whitening agent, and is not limited by the cosmetic base material used. It's not a thing.

したがって本発明においては、化粧料基材として従来よ
り多用されている種々の基礎化粧料基材、たとえば各種
アルコール類、動植物脂肪、界面活性剤、ペクチン、カ
ルボキシメチルセルロース、アルギン酸塩、さらには安
定剤、色素、香料およびその他の成分を適宜配合し、要
すれば加熱熔融または溶融櫨拝したものなどがすべてそ
のまま採用可能である。つぎに、本発明に美白剤おぶび
日焼防止剤として用いられる前記ェステル化物について
、参考例および実施例をあげて詳細に説明する。
Therefore, in the present invention, various basic cosmetic base materials that have been conventionally widely used as cosmetic base materials, such as various alcohols, animal and vegetable fats, surfactants, pectin, carboxymethyl cellulose, alginates, and stabilizers, Colorants, fragrances, and other ingredients may be appropriately blended and, if necessary, heated and melted or melted, and the like can be used as is. Next, the esterified product used in the present invention as a skin whitening agent and sunscreen will be described in detail with reference to reference examples and examples.

参考例 1 (コウジ酸生産能を有するアスベルギルス・アルバスを
培養してえられるコウジ酸)培地としてシュクロース5
%、リン酸2水素カリ0.03%、硫酸マグネシウム0
.01%、塩化カルシウム0.01%、塩化第二鉄0.
001%、塩化ナトリウム0.001%、ベプトン0.
5%の水溶液をpH4に調製したものを用いて、これを
偏平フラスコに事容積分充填し、圧力lkg/めで15
分間高圧殺菌したのち「 この培地にアスベルギルス・
アルバス(宇都宮大学より入手したもの)を接種し、2
8q○で10日間静鷹培養を行なった。
Reference example 1 (Kojic acid obtained by culturing Asbergillus albus having the ability to produce kojic acid) Sucrose 5 as a medium
%, potassium dihydrogen phosphate 0.03%, magnesium sulfate 0
.. 0.01%, calcium chloride 0.01%, ferric chloride 0.01%, calcium chloride 0.01%, ferric chloride 0.
001%, sodium chloride 0.001%, beptone 0.001%, sodium chloride 0.001%, beptone 0.
Using a 5% aqueous solution adjusted to pH 4, the same volume was filled into a flat flask, and the pressure was 15 kg/mm.
After high-pressure sterilization for a minute, add Asbergillus to this medium.
Albus (obtained from Utsunomiya University), 2
Static culture was performed at 8q○ for 10 days.

培養後、菌蓋を除去し、培養液を炉過してコウジ酸2.
5%を含有した発酵液をえた。この発酵液1000の‘
に5%酢酸第2銅400の‘を加え、300仇pmで2
粉ふ間遠0分離して沈殿物150夕をえた。
After culturing, the bacterial lid was removed and the culture solution was filtered to obtain kojic acid 2.
A fermentation liquid containing 5% was obtained. 1000' of this fermented liquid
Add 400' of 5% cupric acetate to
150 minutes of precipitate was obtained after 0 minutes from the powder.

この沈殿物を約1“音量の水1500のとに懸濁させ、
ついで硫化水素を充分に通じて硫化第2銅を沈殿させL
これを炉過により除去してえられた炉液を50q0で
減圧濃縮して濃縮液500のとをえた。この濃縮液を酢
酸エチル2000机【で3回抽出し、えられた酢酸エチ
ル抽出液を減圧下5000で濃縮してコウジ酸の粗結晶
化物25夕をえた。このものを酢酸エチル2000の【
で再結晶してコウジ酸20夕をえた。参考例 2 ミリスチン酸22.8夕(0.1モル)に塩化亜鉛4.
1夕(0.03モル)を濃拝しながら溶解し、1403
○で30分間加熱した。
This precipitate was suspended in approximately 1" volume of 1,500 ml of water,
Next, hydrogen sulfide is sufficiently passed through to precipitate cupric sulfide.
This was removed by furnace filtration, and the obtained furnace liquid was concentrated under reduced pressure at 50q0 to obtain a concentrated liquid of 500ml. This concentrated solution was extracted three times with 2,000 ml of ethyl acetate, and the resulting ethyl acetate extract was concentrated under reduced pressure at 5,000 ml of ethyl acetate to obtain 25 ml of crude crystallized kojic acid. Add this to 2000 ethyl acetate [
It was recrystallized to obtain 20 days of kojic acid. Reference Example 2 22.8 mm (0.1 mol) of myristic acid and 4.8 mm of zinc chloride.
Dissolve 1 night (0.03 mol) while worshiping, 1403
Heated at ○ for 30 minutes.

ついでこの液に純品のコウジ酸(シグマ社製)4.3夕
(0.03モル)を蝿伴下徐々に添加し「 さらに14
000で2.曲時間加熱蝿梓を行なった。このものを室
温で一晩放置したのち、水300机で洗浄し、ついでエ
ーテル2000の上で3回抽出し、エーテル抽出液を炭
酸水素ナトリウムで中和した。
Next, 4.3 moles (0.03 mol) of pure kojic acid (manufactured by Sigma) was gradually added to this solution under the supervision of a ``further 14 mol.''
000 for 2. The song was called Heated Fly Azusa. After standing overnight at room temperature, the mixture was washed with 300 g of water, extracted three times with 200 g of ether, and the ether extract was neutralized with sodium bicarbonate.

該抽出液を減圧下30ooで濃縮して粗結晶生成物13
.5夕をえた。このものをエーテル300Mで再結晶さ
せてコウジ酸とミリスチン酸とのェステル化物12夕を
えた。参考例 3 参考例2で用いたミリスチン酸に代えてステァリン酸2
8.5夕(0.1モル)を用い、かつコウジ酸として参
考例1でえたコウジ酸を用いたほかは、参考例2と同様
にしてコウジ酸とステアリン酸とのェステル化物13夕
をえた。
The extract was concentrated under reduced pressure at 30 oo to obtain a crude crystal product 13.
.. It took 5 evenings. This product was recrystallized with 300M ether to obtain an esterified product of kojic acid and myristic acid. Reference Example 3 Stearic acid 2 was used in place of myristic acid used in Reference Example 2.
An esterified product of kojic acid and stearic acid 13 was obtained in the same manner as in Reference Example 2, except that 8.5% (0.1 mol) was used and the kojic acid obtained in Reference Example 1 was used as kojic acid. .

参考例 4 参考例2で用いたミリスチン酸に代えてカプリル酸14
.4夕(0.1モル)を用いたほかは、参考例2と同様
にしてコウジ酸とカプリル酸とのヱステル化物7.5夕
をえた。
Reference Example 4 Caprylic acid 14 was used instead of myristic acid used in Reference Example 2.
.. A esterified product of kojic acid and caprylic acid, 7.5 mole, was obtained in the same manner as in Reference Example 2, except that 4 mole (0.1 mole) was used.

参考例 5 参考例3で用いたステァリン酸に代えてオレィン酸を用
いたほかは「参考例3と同様にしてコウジ酸とオレィン
酸とのェステル化物12.8夕をえた。
Reference Example 5 An esterified product of kojic acid and oleic acid was obtained in the same manner as in Reference Example 3 except that oleic acid was used in place of the stearic acid used in Reference Example 3.

しかしてえられたコウジ酸の各アシル誘導体の融点およ
び塩化第2鉄試験の結果を純品のコウジ酸の試験結果と
共に、第1表に示した。
The melting points and ferric chloride test results of each acyl derivative of kojic acid thus obtained are shown in Table 1 together with the test results for pure kojic acid.

第 1 表 夫各試料はいずれも0.5〃モル/妙・10%‐ェタノ
ール溶液である。
Table 1 Each sample is a 0.5 mol/10% ethanol solution.

実施例 1〜4参考例2でえられたコウジ酸とミリスチ
ン酸とのェステル化物をエタノールに溶解して濃度1.
0%のIJニメント剤(実施例1)を調製した。
Examples 1 to 4 The esterified product of kojic acid and myristic acid obtained in Reference Example 2 was dissolved in ethanol to a concentration of 1.
A 0% IJ Niment agent (Example 1) was prepared.

同様にして参考例3〜5でえられた各ェステル化物を用
いてそれぞれのリニメント剤(実施例2〜4)を調製し
た。これらリニメント剤のチロジナーゼ活性阻害力を調
べるために、試験管にL−チロジン溶液(0.3の9/
心)を1の上、マックルベィン氏の緩衝液(pH6.8
)を1の上、および実施例1でえられたりニメント剤の
0.9の‘を加えて37℃の恒温水槽中で10分間イン
キュベートしたのち、これにチロジナーゼ溶液(1の9
′机上)を0.1の上加えてよく損拝し、ただちに分光
光度計にセットして475の仏におけるそれぞれの吸光
度を経時的に測定した。
In the same manner, each liniment agent (Examples 2 to 4) was prepared using each esterified product obtained in Reference Examples 3 to 5. In order to examine the ability of these liniment agents to inhibit tyrosinase activity, we placed an L-tyrosine solution (0.3/9/
mucklevaine's buffer (pH 6.8)
) was added to 1 and 0.9' of Niment agent obtained in Example 1, and incubated in a thermostatic water bath at 37°C for 10 minutes.
0.1 (on the desk) was added, the mixture was thoroughly shaken, and the absorbance of each of the 475 Buddhas was measured over time by immediately setting it on a spectrophotometer.

一方、ブランクテストとして前記リニメント剤の代わり
‘こ水を用いて同様の吸光度測定を行なった。同様にし
て実施例2〜4のリニメント剤のチロジナーゼ活性阻害
力を調べた。
On the other hand, as a blank test, similar absorbance measurements were performed using water instead of the liniment agent. In the same manner, the liniment agents of Examples 2 to 4 were examined for their ability to inhibit tyrosinase activity.

比較例 1 純品のコウジ酸を用いて、実施例1〜4と同機にしてリ
ニメント剤を調整し、チロジナーゼ活性阻害力を調べた
Comparative Example 1 A liniment agent was prepared using pure kojic acid in the same manner as in Examples 1 to 4, and its ability to inhibit tyrosinase activity was examined.

第1図は実施例1〜4および比較例1の測定結果を示す
グラフであるが、このグラフから実施例1〜4のリニメ
ント剤はいずれもコウジ酸からなるリニメント剤に比べ
て顕著なチロジナーゼ活性阻害力を有していることがわ
かる。
FIG. 1 is a graph showing the measurement results of Examples 1 to 4 and Comparative Example 1. From this graph, it can be seen that the liniment agents of Examples 1 to 4 all have more significant tyrosinase activity than the liniment agents made of kojic acid. It can be seen that it has an inhibitory power.

実施例 5〜8 参考例2〜5でえられた各ヱステル化物LO夕をそれぞ
れ50%エタノール溶液100の‘に溶解させて各1%
リニメント剤を調製した。
Examples 5 to 8 Each of the esterified compounds obtained in Reference Examples 2 to 5 was dissolved in a 50% ethanol solution of 100% each to 1%
A liniment preparation was prepared.

このものに水酸化ナトリウムを添加してpHを10.0
に調整したもち、温度を50ご0に保ち、それぞれの着
色度を分光光度計(420肌仏)を用いて経時的に測定
した。
Add sodium hydroxide to this to adjust the pH to 10.0.
The degree of coloration of each rice cake was measured over time using a spectrophotometer (420 Hada Buddha) while maintaining the temperature at 50°C.

比較例 2 純品のコウジ酸を用いて実施例5〜8と同様にしてリニ
メント剤を調製して「実施例5〜8と同一条件下で着色
度の変化を調べた。
Comparative Example 2 A liniment agent was prepared in the same manner as in Examples 5 to 8 using pure kojic acid, and changes in the degree of coloration were examined under the same conditions as in Examples 5 to 8.

第2図はこれらの試験結果を示すグラフであるが、この
グラフから実施例5〜8のリニメント剤はいずれもコウ
ジ酸からなるリニメント剤に比べてpHや熱に対する安
定性にすぐれていることがわかる。
Figure 2 is a graph showing the results of these tests, and it can be seen from this graph that all the liniment agents of Examples 5 to 8 have better stability against pH and heat than the liniment agents made of kojic acid. Recognize.

またこれら各リニメント剤に270肌仏の紫外線を照射
し、それぞれの着色度を分光光度計(420肌仏)で経
時的に測定した。
Further, each of these liniment agents was irradiated with ultraviolet light of 270 degrees Celsius, and the degree of coloration of each was measured over time using a spectrophotometer (420 degrees Celsius).

また前記比較例2でえた純品のコウジ酸を用いたりニメ
ント剤についても同様に試験した。第3図はこれらの試
験結果を示すグラフであるが、このグラフから実施例5
〜8のリニメント剤はいずれもコウジ酸からなるリニメ
ント剤に比べて光に対する安定性がすぐれていた。
Further, pure kojic acid obtained in Comparative Example 2 and Nimento agent were also tested in the same manner. FIG. 3 is a graph showing these test results. From this graph, Example 5
All of the liniment agents No. 8 to 8 had better stability against light than the liniment agent made of kojic acid.

実施例 9 参考例2でえたェステル化物を用いて第2表に示す配合
割合でバニシングクリームを調製した。
Example 9 A vanishing cream was prepared using the esterified product obtained in Reference Example 2 at the blending ratio shown in Table 2.

第2表このバニシングクリーム1夕をパネル40名の腕
2c船こ均一に塗布し、この塗布面に1、2および柵岱
D(最小紅斑生成量)で270の仏の紫外線と340の
仏の紫外線とを同時に照射したが、いずれの条件におい
てもパネル全員に紅斑が生じなかった。
Table 2 This vanishing cream was applied evenly to the arms of 40 panelists, and the applied surface was exposed to ultraviolet rays of 270 degrees and 340 degrees of ultraviolet rays at levels 1, 2 and D (minimum amount of erythema produced). Although irradiated with ultraviolet rays at the same time, no erythema occurred on any of the panels under any conditions.

実施例 10 参考例3でえたェステル化物を用いて第3表に示す配合
割合でバニシングクリーム(試験薬S)を調製した。
Example 10 A vanishing cream (test drug S) was prepared using the esterified product obtained in Reference Example 3 at the blending ratio shown in Table 3.

第3表 また比較のため、第3表に示す組成のうち参考例3でえ
られたェステル化物を同量の精製水に代えたバニシング
クリーム(プラセボ)を調製した。
Table 3 For comparison, a vanishing cream (placebo) was prepared by replacing the esterified product obtained in Reference Example 3 with the same amount of purified water among the compositions shown in Table 3.

パネル30名の上腕内側部に2×2肌の区画を2区画設
定し、A区画およびB区画とした。
Two 2×2 skin sections were set up on the inner side of the upper arms of 30 panelists, and were designated as A section and B section.

ついで両区画に10伽の距離からFL2庇・BLBラン
プ2本およびFL2庇・E30ランプ2本を5分間照射
した。照射直後からA区画に試験薬Sを、B区画にプラ
セボを1日3回の割合で7日間塗布し、7日後の色素沈
着の改善の度合を調べた。
Both compartments were then irradiated for 5 minutes with two FL2 eaves/BLB lamps and two FL2 eaves/E30 lamps from a distance of 10 celsius. Immediately after irradiation, test drug S was applied to section A and placebo was applied to section B three times a day for 7 days, and the degree of improvement in pigmentation was examined after 7 days.

結果を第4表に示す。色素沈着の改善の度合は、A区画
(試験薬S塗布)とB区画(プラセボ塗布)との色素沈
着の程度を目視で比較し、B区画に対するA区画の改善
の程度を判定した。
The results are shown in Table 4. The degree of improvement in pigmentation was determined by visually comparing the degree of pigmentation in section A (applied with test drug S) and section B (applied with placebo), and the degree of improvement in section A relative to section B was determined.

第4表 第4表から明らかなごとく、本発明のヱステル化物は人
体に対してプラセボに比して有意に色素沈着を抑えるこ
とができる。
Table 4 As is clear from Table 4, the esterified product of the present invention can significantly suppress pigmentation in the human body compared to the placebo.

以上の実施例から明らかなごとく、本発明の色白化粧料
はその有効成分として前記一般式(1)で示されるコウ
ジ酸のェステル化物を用いることにより、チロジナーゼ
活性阻害力にきわめてすぐれており、また該ェステル化
物は光、pH、熱に対する安定性にすぐれており、しか
も人体に何らの副作用も生じさせるこことがなく、その
美白効果および日焼防止効果がすこぶる大である。
As is clear from the above examples, the skin-whitening cosmetic of the present invention uses the esterified kojic acid represented by the above general formula (1) as its active ingredient, and has an extremely excellent tyrosinase activity inhibiting ability. The esterified product has excellent stability against light, pH, and heat, does not cause any side effects on the human body, and has extremely great whitening and sun protection effects.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は実施例1〜4でえた各リニメント剤のチロジナ
ーゼ活性阻害力を示すための、着色度と時間との関係を
示すグラフ、第2図および第3図は実施例5〜8でえた
各リニメント剤のPHおよび熱に対する安定性を示すた
めの、着色度と時間を示すグラフおよび光に対する安定
性を示すための、着色度と時間との関係を示すグラフで
ある。 第1図第2図 第3図
Figure 1 is a graph showing the relationship between the degree of coloring and time to show the tyrosinase activity inhibiting power of each liniment agent obtained in Examples 1 to 4, and Figures 2 and 3 are graphs obtained in Examples 5 to 8. 1 is a graph showing the degree of coloration versus time to show the stability against pH and heat of each liniment agent; and a graph showing the relationship between the degree of coloration and time to show the stability against light. Figure 1 Figure 2 Figure 3

Claims (1)

【特許請求の範囲】 1 一般式(I) ▲数式、化学式、表等があります▼ (式中、Rは飽和または不飽和脂肪族炭化水素基である
)で示されるコウジ酸のエステル化物を有効成分として
含有せしめたことを特徴とする色白化粧料。 2 エステル化物の含有量が0.01〜10重量%であ
る特許請求の範囲第1項記載の色白化粧料。 3 前記RがC_1以上の飽和脂肪族炭化水素基である
特許請求の範囲第1項記載の色白化粧料。 4 前記RがC_1_3〜C_1_9の飽和脂肪族炭化
水素基である特許請求の範囲第3項記載の色白化粧料。
[Claims] 1 General formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R is a saturated or unsaturated aliphatic hydrocarbon group) A fair-skinned cosmetic characterized by containing it as an ingredient. 2. The fair-skinned cosmetic according to claim 1, wherein the content of the esterified product is 0.01 to 10% by weight. 3. The fair-skinned cosmetic according to claim 1, wherein R is a saturated aliphatic hydrocarbon group of C_1 or more. 4. The fair skin cosmetic according to claim 3, wherein the R is a saturated aliphatic hydrocarbon group of C_1_3 to C_1_9.
JP52160732A 1977-12-29 1977-12-29 fair skin cosmetics Expired JPS607961B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP52160732A JPS607961B2 (en) 1977-12-29 1977-12-29 fair skin cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52160732A JPS607961B2 (en) 1977-12-29 1977-12-29 fair skin cosmetics

Publications (2)

Publication Number Publication Date
JPS5492632A JPS5492632A (en) 1979-07-23
JPS607961B2 true JPS607961B2 (en) 1985-02-28

Family

ID=15721253

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52160732A Expired JPS607961B2 (en) 1977-12-29 1977-12-29 fair skin cosmetics

Country Status (1)

Country Link
JP (1) JPS607961B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545982A (en) * 1982-03-17 1985-10-08 Yakurigaku Chuo Kenkyusho Pyranone compounds and skin-lightening cosmetic preparations or local demelanizing agents containing the same
WO1986000306A1 (en) * 1982-12-29 1986-01-16 Sansho Seiyaku Co., Ltd. Kojic acid derivatives and whitening cosmetics containing same
KR960016127B1 (en) * 1994-02-01 1996-12-04 주식회사 태평양 Kojic acid derivatives
JP3116160B2 (en) * 1997-09-25 2000-12-11 千枝子 椛島 Method for producing basic cosmetic for skin conditioning
JP4658898B2 (en) * 2006-10-20 2011-03-23 花王株式会社 Melanin inhibitor and whitening cosmetic
JP7355518B2 (en) * 2019-03-29 2023-10-03 丸善製薬株式会社 Method for producing peppermint fermented liquid

Also Published As

Publication number Publication date
JPS5492632A (en) 1979-07-23

Similar Documents

Publication Publication Date Title
US4369174A (en) Cosmetic composition containing kojic acid ester
JPS5857307A (en) Cosmetic
US20030072824A1 (en) Ume extract having medicinal effects and compositions containing the same
JPS6326095B2 (en)
JPS609722B2 (en) fair skin cosmetics
JPS6010005B2 (en) fair skin cosmetics
JPS607961B2 (en) fair skin cosmetics
DE2920890C2 (en) Esterastine derivatives and processes for their preparation
JPH03193712A (en) Cosmetic
JPH03101609A (en) External medicine for skin
WO2006106992A1 (en) Melanin production inhibitory agent
JPH05320039A (en) Skin-beautifying cosmetic
CN109503510A (en) A kind of thiazole compound and preparation method thereof of preventing decayed tooth antibacterial
JPS61143314A (en) Emulsion for suppressing formation of melanin
JPS5834477B2 (en) Fatty acid ester of quercetin
JPS58131911A (en) Cosmetic for fair-complexioned face containing fatty acid ester of quercetin
JPH04187618A (en) Skin external preparation
WO1990012800A1 (en) Phospholipid derivatives
JPS6157594A (en) Galactosphingolipid and its production
JPH04198115A (en) Whitening external preparation
JP2006124386A (en) Whitening and antioxidants and active oxygen scavengers
JPS61143313A (en) Lotion for suppressing formation of melanin
JPS5822152B2 (en) Kojic acid monoester
JPH04352708A (en) Cosmetic
JPH02124810A (en) Cosmetic